NIH-funded research NIH-funded research

Tests to predict how Parkinson's will progress

Official title: Biomarkers of disease severity and progression in Parkinson's

Funded at Portland VA Medical Center · NIH-11263612 · Data updated 2026-11-12

Researchers will use a special type of brain scan and blood tests to look for markers that help predict how Parkinson's disease will change over time for people with the condition, especially veterans.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionPortland VA Medical Center
NIH-funded
Lab location1 site (Portland, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2027
Funding year2026
NIH project number5IK2CX002539-04
Project IDNIH-11263612 on NIH RePORTER

Who could benefit from this research

Could help

People diagnosed with Parkinson's disease who can undergo MRI scanning and provide blood samples, including veterans, would be ideal candidates.

Less likely to help

People who cannot have MRI (for example those with certain implanted devices) or who cannot consent due to advanced dementia may not be able to participate or benefit.

What this research studies

You would get a magnetic resonance spectroscopic imaging (MRSI) scan that measures brain energy-related chemicals and give small blood samples for tests of immune cell mitochondrial activity (Nrf2). The team will compare these measures with patients' symptoms and thinking over time to see which patterns link to faster or slower decline. The work focuses on people with Parkinson's, with attention to veterans who have higher disease risk. Results could help doctors spot who is likely to worsen sooner and tailor care or trial enrollment.

Why it matters

Potential benefit: If successful, this could allow earlier identification of patients likely to decline faster, improving counseling, treatment planning, and clinical trial matching.

How similar studies have gone: Prior studies link mitochondrial problems to Parkinson's, but using MRSI plus blood-based Nrf2 measures together as predictive biomarkers for progression is relatively new and unproven.

Where this research is happening

  • Portland VA Medical Center
    Portland, United States
    Active

Researchers

  • Principal investigator: Neilson, Lee — Portland VA Medical Center
  • Study coordinator: Neilson, Lee

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.